Functional electrical stimulation plus physiotherapy for severe post-stroke ICU-acquired weakness
Official title: Intensive Rehabilitation by Functional Electrical Stimulation for the Treatment of Critical Neuromyopathy in Patients With Severe Stroke Admitted to the Highly Specialized Intensive Rehabilitation Unit: a Pilot Study
Run by Fondazione Don Carlo Gnocchi ETS · NCT07130929 · Data updated 2026-11-12
This pilot will try using functional electrical stimulation together with physiotherapy to help adults with recent severe stroke who developed ICU-acquired weakness regain strength and movement.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | Fondazione Don Carlo Gnocchi ETS Academic / other |
| Locations | 1 site (Florence, FI) |
| Status | Recruiting |
| Started | September 23, 2025 |
| Main results expected | September 23, 2026 |
| Study ends | March 23, 2027 |
| Registry record updated | December 11, 2025 |
| Trial ID | NCT07130929 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–80 with ischemic or hemorrhagic stroke within three months, premorbid mRS <2, cognitive ability for active participation, clinical and neurophysiological confirmation of ICU‑AW with MRC sum ≤48, and no contraindications to FES.
✕Probably not a fit
Patients with hemodynamic or respiratory instability, uncontrolled epilepsy, implanted electronic devices, severe spasticity (>3), chronic neuropathy, skin integrity problems at electrode sites, pregnancy or breastfeeding, or other listed exclusions are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot enrolls a small group of adults with severe acquired brain injury from ischemic or hemorrhagic stroke who have a clinical and neurophysiological diagnosis of ICU-acquired weakness. Participants receive conventional physiotherapy sessions augmented by surface functional electrical stimulation (FES) applied to target muscles while they actively perform motor tasks under physiotherapist supervision. The combined approach aims to promote neuroplasticity and muscle reactivation by pairing repetitive, task-oriented movement with timed electrical stimulation. Outcomes will focus on changes in muscle strength, motor function, and relevant neurophysiological measures over the treatment period.
Why it matters
Potential benefit: If successful, this approach could speed recovery of muscle strength and improve functional mobility after severe stroke-related ICU-acquired weakness.
How similar studies have gone: FES has shown positive signals for strength and function in other post-stroke and ICU rehabilitation programs, but high-quality evidence specifically in severe ICU‑AW is limited and this application remains exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of ischemic or hemorrhagic vascular GCA involving unilateral motor deficit \< 3 months; * Premorbid Modified Rankin Scale \<2; * Age \>18 years and \<80 years; * Level of Cognitive Functioning \> 4 for active participation in treatment. * MRC total sum score \<= 48 (range 0 -60) for clinical suspicion of ICU-AW * Clinical diagnosis of tetra/paraparesis of peripheral origin confirmed by neurophysiological examination; * Signature of informed consent by the patient or, if incapacitated, by their legal representative. Exclusion Criteria: * Clinical cardio-respiratory or internal instability such as to prevent treatment; * History of previous comorbidity for ICU-AW; * Previous known chronic neuropathy; * Severe coagulopathy; * Skin integrity problems at the interface surfaces with the electrostimulator; * Epilepsy not controlled by medication; * Presence of implanted electronic devices; * Pregnancy or breastfeeding; * Severe spasticity with a score of \>3 on the modified Ashworth scale; * Treatment with botulinum toxin; * Recent malignant neoplasm; * Conditions that put you at risk for neuropathies, e.g., history of diabetes mellitus, renal failure, hepatic failure, vitamin deficiencies, chronic alcoholism, vasculitis, previous use of neurotoxic drugs.
Where it's running
-
IRCCS-Fondazione Don Gnocchi
Florence, Fi, Italy Recruiting
Study contacts
- Study coordinator: Bahia Hakiki
- Email: bhakiki@dongnocchi.it
- Phone: 00390557393906
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Brain-computer interface neurofeedback to improve thinking skills after brain injury
Researchers are testing a brain-computer interface neurofeedback program to see if it can improve attention, memory, and executive function in kids and teens who have had a brain injury or epilepsy, compared with standard care.
-
Neurofeedback and tRNS for Attention After Brain Injury
This study tests whether neurofeedback combined with transcranial random noise stimulation can help adults with attention problems after brain injury.
-
Handwriting rehabilitation after brain injury using Functional Electrical Stimulation (FES)
This study tests whether Functional Electrical Stimulation can help people who have hand weakness after a brain injury improve handwriting.
-
Able Kids device: safer gait aid for kids with neurologic gait problems
This study tests whether the ABLE Kids wearable exoskeleton can be safely used during a 10-session gait training program for children with neurological gait disorders or muscle weakness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.